BioPharma Credit PLC (BPCR) — Strategic Asset Allocation Index
BioPharma Credit PLC (BPCR) has a Strategic Asset Allocation Index of 98.4% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $1.16 Billion) total $1.16 Billion, measured against net assets of $1.18 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see BPCR company net worth.
SAAI
Strategic Assets
PP&E
Net Assets
BioPharma Credit PLC Strategic Asset Allocation Index (2017–2024)
This chart shows how BioPharma Credit PLC's Strategic Asset Allocation Index has evolved across 8 annual periods from 2017 to 2024. As of December 2024, the index stands at 98.4%, representing strategic assets of $1.16 Billion against net assets of $1.18 Billion USD. See BioPharma Credit PLC (BPCR) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for BioPharma Credit PLC (2017–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for BioPharma Credit PLC from 2017 to 2024, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore BioPharma Credit PLC (BPCR) net asset momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.4% | $1.16 Billion | $- | $1.16 Billion | $1.18 Billion | ▲ +8.8 pp |
| 2023 | 89.6% | $1.20 Billion | $- | $1.20 Billion | $1.34 Billion | ▼ -1.9 pp |
| 2022 | 91.5% | $1.22 Billion | $- | $1.22 Billion | $1.34 Billion | ▼ -1.4 pp |
| 2021 | 92.8% | $1.27 Billion | $- | $1.27 Billion | $1.36 Billion | ▲ +6.2 pp |
| 2020 | 86.7% | $1.19 Billion | $- | $1.19 Billion | $1.38 Billion | ▲ +7.1 pp |
| 2019 | 79.5% | $1.12 Billion | $- | $1.12 Billion | $1.40 Billion | ▲ +6.5 pp |
| 2018 | 73.0% | $1.01 Billion | $- | $1.01 Billion | $1.38 Billion | ▲ +11.2 pp |
| 2017 | 61.7% | $569.63 Million | $- | $569.63 Million | $922.57 Million | — |